rs147950418
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_001130987.2(DYSF):c.4021C>G(p.Gln1341Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00151 in 1,614,040 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Q1341Q) has been classified as Likely benign.
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DYSF | NM_001130987.2 | c.4021C>G | p.Gln1341Glu | missense_variant | 37/56 | ENST00000410020.8 | |
DYSF | NM_003494.4 | c.3967C>G | p.Gln1323Glu | missense_variant | 37/55 | ENST00000258104.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DYSF | ENST00000410020.8 | c.4021C>G | p.Gln1341Glu | missense_variant | 37/56 | 1 | NM_001130987.2 | A1 | |
DYSF | ENST00000258104.8 | c.3967C>G | p.Gln1323Glu | missense_variant | 37/55 | 1 | NM_003494.4 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.000953 AC: 145AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000865 AC: 217AN: 250804Hom.: 1 AF XY: 0.000745 AC XY: 101AN XY: 135552
GnomAD4 exome AF: 0.00156 AC: 2285AN: 1461704Hom.: 5 Cov.: 32 AF XY: 0.00146 AC XY: 1062AN XY: 727134
GnomAD4 genome ? AF: 0.000952 AC: 145AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.000846 AC XY: 63AN XY: 74492
ClinVar
Submissions by phenotype
not provided Uncertain:5Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 28, 2020 | This variant is associated with the following publications: (PMID: 25133958, 29970176) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 20, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 14, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 29, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 14, 2020 | - - |
Qualitative or quantitative defects of dysferlin Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Miyoshi muscular dystrophy 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 16, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported in patients with ataxia and limb-girdle muscular dystrophy [PMID 25133958, 29970176] - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at